Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 550

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Glucose metabolism and cancer

Shaw, Reuben J·2006·Current Opinion in Cell Biology
DOI 10.1016/j.ceb.2006.10.005
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ceb.2006.10.005

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 63

  1. Warburg, 1956, On the origin of cancer cells, Science, 123, 309
  2. Garber, 2006, Energy deregulation: licensing tumors to grow, Science, 312, 1158
  3. Gambhir, 2002, Molecular imaging of cancer with positron emission tomography, Nat Rev Cancer, 2, 683
  4. Kahn, 2005, AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism, Cell Metab, 1, 15
  5. Hardie, 2006, AMP-activated protein kinase — development of the energy sensor concept, J Physiol, 574, 7
  6. Alessi, 2006, Lkb1-dependent signaling pathways, Annu Rev Biochem, 75, 137
  7. Hearle, 2006, Frequency and spectrum of cancers in the Peutz-Jeghers syndrome, Clin Cancer Res, 12, 3209
  8. Sanchez-Cespedes, 2002, Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung, Cancer Res, 62, 3659
  9. Carretero, 2004, Novel and natural knockout lung cancer cell lines for the LKB1/STK11 tumor suppressor gene, Oncogene, 23, 4037
  10. Hawley, 2003, Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25α/β are upstream kinases in the AMP-activated protein kinase cascade, J Biol, 2, 28
  11. Sakamoto, 2005, Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction, EMBO J, 24, 1810
  12. Hurley, 2005, The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases, J Biol Chem, 280, 29060
  13. Woods, 2005, C(Ca2+)/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells, Cell Metab, 2, 21
  14. Stahmann, 2006, Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase β, Mol Cell Biol, 26, 5933
  15. Wullschleger, 2006, TOR signaling in growth and metabolism, Cell, 124, 471
  16. Bader, 2005, Oncogenic PI3K deregulates transcription and translation, Nat Rev Cancer, 5, 921
  17. Corradetti, 2004, Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome, Genes Dev, 18, 1533
  18. Shaw, 2004, The LKB1 tumor suppressor negatively regulates mTOR signaling, Cancer Cell, 6, 91
  19. Inoki, 2006, TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth, Cell, 126, 955
  20. Liu, 2006, Hypoxia-induced energy stress regulates mRNA translation and cell growth, Mol Cell, 21, 521
  21. Carretero J, Medina PP, Blanco R, Smit L, Tang M, Roncador G, Maestre L, Conde E, Lopez-Rios F, Clevers HC, et al.: Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene 2006, in press.
  22. Johannessen, 2005, The NF1 tumor suppressor critically regulates TSC2 and mTOR, Proc Natl Acad Sci USA, 102, 8573
  23. Imamura, 2001, Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line, Biochem Biophys Res Commun, 287, 562
  24. Jones, 2005, AMP-activated protein kinase induces a p53-dependent metabolic checkpoint, Mol Cell, 18, 283
  25. Igata, 2005, Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression, Circ Res, 97, 837
  26. Mandal, 2005, Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila, Dev Cell, 9, 843
  27. Bettencourt-Dias, 2004, Genome-wide survey of protein kinases required for cell cycle progression, Nature, 432, 980
  28. Moffat, 2006, A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen, Cell, 124, 1283
  29. Bardeesy, 2002, Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation, Nature, 419, 162
  30. Laderoute, 2006, 5′-AMP-activated protein kinase (AMPK) Is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments, Mol Cell Biol, 26, 5336
  31. Semenza, 1994, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1, J Biol Chem, 269, 23757
  32. Iyer, 1998, Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha, Genes Dev, 12, 149
  33. Ryan, 1998, HIF-1 alpha is required for solid tumor formation and embryonic vascularization, EMBO J, 17, 3005
  34. Greijer, 2005, Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1), J Pathol, 206, 291
  35. Kim, 2004, Role of VHL gene mutation in human cancer, J Clin Oncol, 22, 4991
  36. Brugarolas, 2004, Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes, Cancer Cell, 6, 7
  37. Dekanty, 2005, The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-α/Sima, J Cell Sci, 118, 5431
  38. Brugarolas, 2003, TSC2 regulates VEGF through mTOR-dependent and -independent pathways, Cancer Cell, 4, 147
  39. Blancher, 2001, Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway, Cancer Res, 61, 7349
  40. Li, 2005, A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells, Cancer Res, 65, 3257
  41. Reiling, 2004, The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6K activity upstream of TSC in Drosophila, Genes Dev, 18, 2879
  42. Pozuelo Rubio, 2003, 14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase, EMBO J, 22, 3514
  43. Majewski, 2004, Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak, Mol Cell, 16, 819
  44. Marsin, 2000, Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia, Curr Biol, 10, 1247
  45. Almeida, 2004, Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway, Nat Cell Biol, 6, 45
  46. Kim, 2006, HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, Cell Metab, 3, 177
  47. Papandreou, 2006, HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption, Cell Metab, 3, 187
  48. Bui, 2006, Cancer's sweet tooth, Cancer Cell, 9, 419
  49. Ullah, 2006, The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism, J Biol Chem, 281, 9030
  50. Bensaad, 2006, TIGAR, a p53-inducible regulator of glycolysis and apoptosis, Cell, 126, 107
  51. Gottlieb, 2005, Mitochondrial tumour suppressors: a genetic and biochemical update, Nat Rev Cancer, 5, 857
  52. Pollard, 2005, Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations, Hum Mol Genet, 14, 2231
  53. Ramanathan, 2005, Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements, Proc Natl Acad Sci USA, 102, 5992
  54. Telang S, Yalcin A, Clem AL, Bucala R, Lane AN, Eaton JW, Chesney J: Ras transformation requires metabolic control by 6-phosphofructo-2-kinase. Oncogene 2006, in press.
  55. Hatzivassiliou, 2005, ATP citrate lyase inhibition can suppress tumor cell growth, Cancer Cell, 8, 311
  56. Ryan, 2000, Hypoxia-inducible factor-1α is a positive factor in solid tumor growth, Cancer Res, 60, 4010
  57. Rankin, 2005, Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice, Mol Cell Biol, 25, 3163
  58. Bedogni, 2005, The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation, Cancer Cell, 8, 443
  59. Granville, 2006, Handicapping the race to develop inhibitors of the phosphoinositide 3-kinase/Akt/mammalian target of rapamycin pathway, Clin Cancer Res, 12, 679
  60. Serkova, 2005, Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications, Am J Pharmacogenomics, 5, 293
  61. Motoshima, 2006, AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer, J Physiol, 574, 63
  62. He, 2006, Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity, Cancer Res, 66, 1873
  63. Schneider, 2001, Prevention of pancreatic cancer induction in hamsters by metformin, Gastroenterology, 120, 1263

Cited by

See all 550

Metadata

Authors
Shaw, R. J.
Venue
Current Opinion in Cell Biology
Publisher
Elsevier BV
Published
2006-12
Volume
18
Issue
6
Pages
598-608
ISSN
0955-0674 (ISSN-L)
DOI
10.1016/j.ceb.2006.10.005
OpenAlex
W2045962235
Cited by
550
References
25
FWCI
1.51
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.